loader2
Partner With Us NRI

Jenburkt Pharmaceuticals Ltd share Price Today

Company details

859.75
899.00
586.90
925.00
6M Return 21.82%
1Y Return 22.80%
Mkt Cap.(Cr) 387.88
Volume 3,148
Div Yield 1.74%
OI
-
OI Chg %
-
Volume 3,148

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Jenburkt Pharmaceuticals Ltd shares SWOT Analysis

Strengths (8)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Growth in Net Profit with increasing Profit Margin (QoQ)
  • Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Weakness (0)

Data not found

Opportunity (2)

  • Negative to Positive growth in Sales and Profit with Strong Price momentum
  • RSI indicating price strength

Threats (1)

  • Promoter decreasing their shareholding

Resistance and support

R1 897.8
R2 918.0
R3 937.0
Pivot

878.77

S1 858.5
S2 839.5
S3 819.3
EMA SMA
861.2
829.3
799.5
765.2
860.4
824.0
786.2
747.6
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
JENBURKT PHARMACEUTICALS LTD Bulk Purchase 2023-01-06 649.97 47037 BSE
ARIES STOCKTRADES PVT LTD A/C-PMS Bulk Sell 2020-08-25 410.39 26000 BSE
KETAN JAYANTILAL KARANI (HUF) Bulk Purchase 2018-02-08 540.5 26000 BSE
Name Category Shares
JAYSHREE UTTAM BHUTA PROMOTER 12.16%
KALINDI HEMENDRA BHUTA PROMOTER 9.06%
ASHISH UTTAM BHUTA PROMOTER 5.92%
MAHESH H BHUTA PROMOTER 1.54%
BHAVIKA ASHISH BHUTA PROMOTER 1.17%
KUNTI KETAN GALA PROMOTER 1.16%
RIDDHI HARESH SHROFF PROMOTER 0.73%
JAGRUTI KETAN BHUTA PROMOTER 0.63%
PRAKASH H BHUTA PROMOTER 0.52%
BHUTA HOLDINGS PRIVATE LIMITED PROMOTER 13.96%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Jenburkt Pharmaceuticals Ltd Stocks COMPARISON

Financials( in Cr) Jenburkt Pharmaceuticals Ltd Sun Pharmaceuticals Industries Ltd Divis Laboratories Ltd Cipla Ltd Zydus Lifesciences Ltd
Price 878.95 1,568.40 4,629.70 1,509.90 1,162.45
% Change 0.06 0.67 1.88 1.97 2.23
Mcap Cr 387.88 376,311.70 122,904.18 121,904.34 116,969.67
Revenue TTM Cr 141.97 43,885.68 7,767.51 15,790.60 17,237.40
Net Profit TTM Cr 25.98 8,560.84 1,823.38 2,513.47 1,997.30
PE TTM 14.93 37.61 76.78 28.63 30.34
1 Year Return 22.80 49.54 30.41 49.22 102.48
ROCE 25.67 16.79 19.30 14.76 16.25
ROE 19.44 16.46 14.89 10.66 14.05
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 144.94 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 32,034.54 42,550.31
LAST 3M 115,875.16 11,073.47
LAST 6M 199,586.16 4,620.47
LAST 12M 310,244.99 83,919.34

Jenburkt Pharmaceuticals Ltd Information

Stock PE (TTM)
14.93
Promoter Holding
47.23%
Book Value
328.4168
ROCE
25.67%
ROE
19.44%
Description
  • Jenburkt Pharmaceuticals Ltd, incorporated in 1985, was formed a venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family. The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products. Presently, the Company manufactures and markets pharmaceutical formulations in India and internationally across 13 countries. It has more than 1,000 stockists and their reach extends to 400,000 pharmacies across the globe. The organisation caters to government, semi-government institutions, missionary hospitals, public sector enterprises, etc. Apart from this. the Company operate manufacturing plant at Sihor-Gujarat, approved as per W.H.O (World Health Organisation) guidelines with current Good Manufacturing Practices (GMP) requirements. In addition, it has a Research & Development unit duly approved by the Ministry of Science & Technology, Government of India. Hence, the Company has strong manufacturing facilities to cater to domestic and international market. The purpose of the Company is to serve those in need of quality healthcare by bringing revolutionary, life-changing therapeutic solutions that are accessible to all. Way back in the 20th century, a visionary in the field of healthcare and philanthropic work - Shri Nandlal Mulji Bhuta laid the foundation for several groups of companies. Continuing the legacy of Shri Nandlal Mulji Bhuta, his sons Mr. Uttam N. Bhuta and Mr. Hemendra N. Bhuta founded the Company. In 2021-22, the Company launched a new OTC division ~ Jenburkt Wellness towards better physical and mental health. The first brand launched was Zixa Strong, natural, pain relief product. Further, it launched Nervijen D3 tablets in 2022-23.

Registered Address

Nirmala Apartment P B No 37396, 93 Jayprakash Road Andheri(W), Mumbai, Maharashtra, 400058

Tel : 91-22-66943121/67603603
Email : investor:jenburkt.com
Website : http://www.jenburkt.com
Registrar

Bigshare Services Pvt Ltd

AGM Date (Month) : Jul
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524731
NSE Code :
Book Closure Date (Month) : Jul
BSE Group : X
ISIN : INE354A01013

FAQ’s on Jenburkt Pharmaceuticals Ltd Shares

You can buy Jenburkt Pharmaceuticals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Jenburkt Pharmaceuticals Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jul 05, 2024 04:01 PM the closing price of Jenburkt Pharmaceuticals Ltd was Rs.878.95.

The latest PE ratio of Jenburkt Pharmaceuticals Ltd as of Jul 05, 2024 04:01 PM is 14.93

The latest PB ratio of Jenburkt Pharmaceuticals Ltd as of Jul 05, 2024 04:01 PM is 0.37

The 52-week high of Jenburkt Pharmaceuticals Ltd share price is Rs. 925.00 while the 52-week low is Rs. 586.90

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jul 05, 2024 04:01 PM, the market cap of Jenburkt Pharmaceuticals Ltd stood at Rs. 387.88 Cr.

Download App

Download Our App

Play Store App Store
market app